A Novel Mechanism for SIRT1 Activators That Does Not Rely on the Chemical Moiety Immediately C-Terminal to the Acetyl-Lysine of the Substrate
SIRT1, an NAD<sup>+</sup>-dependent deacetylase, catalyzes the deacetylation of proteins coupled with the breakdown of NAD<sup>+</sup> into nicotinamide and 2′-O-acetyl-ADP-ribose (OAADPr). Selective SIRT1 activators have potential clinical applications in atherosclerosis, ac...
Main Authors: | Nian-Da Yu, Bing Wang, Xin-Zhu Li, Hao-Zhen Han, Dongxiang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/9/2714 |
Similar Items
-
ADP-Ribosylation as Post-Translational Modification of Proteins: Use of Inhibitors in Cancer Control
by: Palmiro Poltronieri, et al.
Published: (2021-10-01) -
PARG suppresses tumorigenesis and downregulates genes controlling angiogenesis, inflammatory response, and immune cell recruitment
by: Sarah Johnson, et al.
Published: (2022-05-01) -
SIRT1 activators as novel therapy for cancer
by: Marwah Saad Joudah, et al.
Published: (2019-08-01) -
Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson’s Disease
by: Rui Wang, et al.
Published: (2020-09-01) -
Acetylation of Mitochondrial Proteins in the Heart: The Role of SIRT3
by: Rebecca M. Parodi-Rullán, et al.
Published: (2018-08-01)